1-3 of 3
Jianguo Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

M7583 Is a Highly Selective and Potent Second Generation BTK Inhibitor for Treatment of B-Cell Malignancies

Samantha M. Goodstal, PhD, Jianguo Ma, Jing Lin, Timothy Crandall, Lindsey Crowley, Andrew Bender, Riham Iadevaia, Anderson Clark
Journal: Blood
Blood (2017) 130 (Supplement 1): 3845.
https://doi.org/10.1182/blood.V130.Suppl_1.3845.3845
Published: 2017
Journal Articles

The Novel Aurora Kinase Inhibitor AS703569 Shows Potent Anti-Tumor Activity in Acute Myeloid Leukemia (AML).

Samantha Sarno, PhD, Jamie Shaw, B.S., Edward Spooner, B.S., Jianguo Ma, Ph.D., Ann Clark, Ph.D., Charles Dumontet, M.D., Ph.D., Angela Romanelli, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 915.
https://doi.org/10.1182/blood.V110.11.915.915
Published: 2007
Journal Articles

The IMPDH Inhibitor VX-944 Demonstrates In Vivo Efficacy in an Aggressive Leukemia Model.

Jugnu Jain, PhD, Jianguo Ma, PhD, Brinley Furey, BS, Christian Recher, MS, Cecile Demur, PhD, Srinivasu Poondru, PhD, Jianbo Zhang, PhD, Shaolan Li, MD, Brant Firestone, BS, Karen Olson, PhD, Maura Murphy, PhD, Jennifer Taylor, PhD, Greg Henkel, PhD, Edward Ball, MD, Yung-Mae Yao, PhD, Susan Almquist, MS, Russell Hoover, PhD
Journal: Blood
Blood (2004) 104 (11): 2530.
https://doi.org/10.1182/blood.V104.11.2530.2530
Published: 2004